Northeast Financial Consultants Inc Rallybio Corp Transaction History
Northeast Financial Consultants Inc
- $2.34 Billion
- Q4 2024
A detailed history of Northeast Financial Consultants Inc transactions in Rallybio Corp stock. As of the latest transaction made, Northeast Financial Consultants Inc holds 96,422 shares of RLYB stock, worth $72,316. This represents 0.0% of its overall portfolio holdings.
Number of Shares
96,422
Previous 22,088
336.54%
Holding current value
$72,316
Previous $25,000
268.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding RLYB
# of Institutions
49Shares Held
32.9MCall Options Held
0Put Options Held
0-
Viking Global Investors LP4.19MShares$3.15 Million0.01% of portfolio
-
Johnson & Johnson New Brunswick, NJ3.64MShares$2.73 Million1.19% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA3.63MShares$2.72 Million1.55% of portfolio
-
New Leaf Venture Partners, L.L.C. New York, NY3.3MShares$2.48 Million4.27% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX3.03MShares$2.27 Million0.08% of portfolio
About Rallybio Corp
- Ticker RLYB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,132,000
- Market Cap $24.1M
- Description
- Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of feta...